Ana Villa María

Institutions of which they are part

Research technician
Pediatric Neurology

Vall Hebron Institut de Recerca

Ana Villa María

Institutions of which they are part

Research technician
Pediatric Neurology

Vall Hebron Institut de Recerca

Related news

The FDA approves a treatment co-created at Vall d’Hebron for a rare muscle disease

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

A new clinical algorithm increases the diagnosis rate of rare diseases

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Vall d'Hebron trains future professionals in the use of gene therapy

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.